Edition:
India

Melinta Therapeutics Inc (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

4.33USD
18 Apr 2019
Change (% chg)

$0.06 (+1.41%)
Prev Close
$4.27
Open
$4.27
Day's High
$4.40
Day's Low
$4.18
Volume
36,872
Avg. Vol
88,469
52-wk High
$45.88
52-wk Low
$3.22

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 35.49 -3.930
Sep '18 34.08 -2.487
Jun '18 12.02 -6.921
Mar '18 14.84 -4.760
FY 2017 Dec '17 4.23 -7.401
Sep '17 1.72 -4.932
Jun '17 0.86 -5.842
Mar '17 4.87 -10.919
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 4 16.14 18.70 14.50 28.61
Quarter Ending Sep-19 4 19.15 21.20 16.76 32.22
Year Ending Dec-19 5 72.78 77.00 66.01 108.12
Year Ending Dec-20 5 113.70 160.00 98.00 158.78
Earnings (per share)
Quarter Ending Jun-19 4 -2.87 -1.93 -3.47 -3.50
Quarter Ending Sep-19 4 -2.66 -1.99 -3.32 -3.20
Year Ending Dec-19 5 -10.58 -7.91 -13.26 -18.79
Year Ending Dec-20 5 -5.30 -2.80 -9.69 -13.86
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -34.03 32.11 --
EPS (TTM) % -12.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Melinta Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.79 -2.68 87 --
13 Week -29.44 -32.88 23 --
26 Week -17.53 -23.80 66 --
52 Week -85.69 -87.87 5 --
YTD 13.39 -0.42 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 60.77%
# of Holders: 104
Total Shares Held: 6,824,653
3 Mo. Net Change: -107,746
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 5
# Reduced Positions: 7
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.